Home  |   About  |   Theory  |   Tutorials  |   FAQ  |   Bahar Lab  |   Statistics


Network of interactions between drugs (red spheres) and targets (blue spheres) is displayed above.
The red lines are used for the predicted interactions and the thickness of edges indicate the confidence score of predictions.

Data source: DrugBank-all; Query type: chemical; # of requested predictions: 20; Secondary interactions: no
Input drug 1: DB00030
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
1 Approved;
BiotechDrug DB00030 Insulin Human Thumb

12 known interactions (targets) of input drug (DB00030): Insulin Human
No. Gene UniProt ID Protein Name Pathway PDB
1 IDE P14735 Insulin-degrading enzyme hsa05010
2 CPE P16870 Carboxypeptidase E hsa04940 NA
3 INSR P06213 Insulin receptor hsa04010; hsa04014; hsa04015; hsa04022; hsa04066; hsa04068; hsa04072; hsa04150; hsa04151; hsa04152; hsa04211; hsa04213; hsa04520; hsa04910; hsa04913; hsa04923; hsa04930; hsa04931; hsa04932; hsa04960
4 CTSD P07339 Cathepsin D hsa04071; hsa04140; hsa04142; hsa04210; hsa04915; hsa05152 1LYA; 1LYB; 1LYW; 4OBZ; 4OC6; 4OD9
5 LRP2 P98164 Low-density lipoprotein receptor-related protein 2 hsa04340; hsa04918; hsa04979 2M0P
6 IGF1R P08069 Insulin-like growth factor 1 receptor hsa01521; hsa01522; hsa04010; hsa04014; hsa04015; hsa04066; hsa04068; hsa04114; hsa04140; hsa04144; hsa04150; hsa04151; hsa04152; hsa04211; hsa04213; hsa04510; hsa04520; hsa04550; hsa04730; hsa04913; hsa04914; hsa05200; hsa05202; hsa05205; hsa05214; hsa05215; hsa05218; hsa05224; hsa05225 1IGR; 1JQH; 1K3A; 1M7N; 1P4O; 2OJ9; 2ZM3; 3D94; 3F5P; 3I81; 3LVP; 3LW0; 3NW5; 3NW6; 3NW7; 3O23; 3QQU; 4D2R; 4XSS
7 SYTL4 Q96C24 Synaptotagmin-like protein 4 NA 2CSZ; 3FDW
8 PCSK2 P16519 Neuroendocrine convertase 2 NA NA
9 RB1 P06400 Retinoblastoma-associated protein hsa01522; hsa04110; hsa04218; hsa04934; hsa05161; hsa05163; hsa05165; hsa05166; hsa05167; hsa05169; hsa05200; hsa05203; hsa05212; hsa05214; hsa05215; hsa05218; hsa05219; hsa05220; hsa05222; hsa05223; hsa05224; hsa05225; hsa05226 1AD6; 1GH6; 1GUX; 1H25; 1N4M; 1O9K; 1PJM; 2AZE; 2QDJ; 2R7G; 3N5U; 3POM; 4CRI; 4ELJ; 4ELL
10 NOV P48745 Protein NOV homolog NA NA
11 IGFBP7 Q16270 Insulin-like growth factor-binding protein 7 NA NA
12 PCSK1 P29120 Neuroendocrine convertase 1 NA NA

20 predicted interactions (targets) of input drug (DB00030): Insulin Human
No. Gene UniProt ID Protein Name Pathway PDB Confidence score
1 HLA-DQA2 P01906 HLA class II histocompatibility antigen, DQ alpha 2 chain hsa04145; hsa04514; hsa04612; hsa04640; hsa04658; hsa04659; hsa04672; hsa04940; hsa05140; hsa05145; hsa05150; hsa05152; hsa05164; hsa05166; hsa05168; hsa05169; hsa05310; hsa05320; hsa05321; hsa05322; hsa05323; hsa05330; hsa05332; hsa05416 NA 55.9%
2 HLA-DQB1 P01920 HLA class II histocompatibility antigen, DQ beta 1 chain hsa04145; hsa04514; hsa04612; hsa04640; hsa04658; hsa04659; hsa04672; hsa04940; hsa05140; hsa05145; hsa05150; hsa05152; hsa05164; hsa05166; hsa05168; hsa05169; hsa05310; hsa05320; hsa05321; hsa05322; hsa05323; hsa05330; hsa05332; hsa05416 1JK8; 1NBN; 1S9V; 1UVQ; 2NNA; 4GG6; 4OZF; 4OZG; 4OZH; 4OZI 51.0%
3 NOS2 P35228 Nitric oxide synthase, inducible hsa00220; hsa00330; hsa01100; hsa04020; hsa04066; hsa04146; hsa04371; hsa04926; hsa05132; hsa05133; hsa05140; hsa05142; hsa05145; hsa05146; hsa05152; hsa05200; hsa05222 1NSI; 2LL6; 2NSI; 3E7G; 3EJ8; 3HR4; 4CX7; 4NOS 31.6%
4 NOS3 P29474 Nitric oxide synthase, endothelial hsa00220; hsa00330; hsa01100; hsa04020; hsa04022; hsa04066; hsa04071; hsa04151; hsa04370; hsa04371; hsa04611; hsa04915; hsa04921; hsa04926; hsa04931; hsa04933; hsa05418 1M9J; 1M9K; 1M9M; 1M9Q; 1M9R; 1NIW; 2LL7; 2MG5; 3EAH; 3NOS; 4D1O; 4D1P 25.7%
5 DHODH Q02127 Dihydroorotate dehydrogenase (quinone), mitochondrial hsa00240; hsa01100 24.7%
6 AHR P35869 Aryl hydrocarbon receptor hsa04659; hsa04934 NA 23.9%
7 F10 P00742 Coagulation factor X hsa04610
1C5M; 1EZQ; 1F0R; 1F0S; 1FAX; 1FJS; 1FXY; 1G2L; 1G2M; 1HCG; 1IOE; 1IQE; 1IQF; 1IQG; 1IQH; 1IQI; 1IQJ; 1IQK; 1IQL; 1IQM; 1IQN; 1KSN; 1LPG; 1LPK; 1LPZ; 1LQD; 1MQ5; 1MQ6; 1MSX; 1NFU; 1NFW; 1NFX; 1NFY; 1NL8; 1P0S; 1V3X; 1WU1; 1XKA; 1XKB; 1Z6E; 2BMG; 2BOH; 2BOK; 2BQ6; 2BQ7; 2BQW; 2CJI; 2D1J; 2EI6; 2EI7; 2EI8; 2FZZ; 2G00; 2GD4; 2H9E; 2J2U; 2J34; 2J38; 2J4I; 2J94; 2J95; 2JKH; 2P16; 2P3F; 2P3T; 2P3U; 2P93; 2P94; 2P95; 2PHB; 2PR3; 2Q1J; 2RA0; 2UWL; 2UWO; 2UWP; 2VH0; 2VH6; 2VVC; 2VVU; 2VVV; 2VWL; 2VWM; 2VWN; 2VWO; 2W26; 2W3I; 2W3K; 2WYG; 2WYJ; 2XBV; 2XBW; 2XBX; 2XBY; 2XC0; 2XC4; 2XC5; 2Y5F; 2Y5G; 2Y5H; 2Y7X; 2Y7Z; 2Y80; 2Y81; 2Y82; 3CEN; 3CS7; 3ENS; 3FFG; 3HPT; 3IIT; 3K9X; 3KL6; 3KQB; 3KQC; 3KQD; 3KQE; 3LIW; 3M36; 3M37; 3Q3K; 3SW2; 3TK5; 3TK6; 4A7I; 4BTI; 4BTT; 4BTU; 4Y6D; 4Y71; 4Y76; 4Y79; 4Y7A; 4Y7B
8 CAPN1 P07384 Calpain-1 catalytic subunit hsa04141; hsa04210; hsa04217; hsa04218; hsa05010 1ZCM; 2ARY 23.5%
9 VEGFA P15692 Vascular endothelial growth factor A hsa01521; hsa04010; hsa04014; hsa04015; hsa04066; hsa04151; hsa04370; hsa04510; hsa04926; hsa04933; hsa05163; hsa05165; hsa05167; hsa05200; hsa05205; hsa05206; hsa05211; hsa05212; hsa05219; hsa05323; hsa05418 23.2%
10 ABCC8 Q09428 ATP-binding cassette sub-family C member 8 hsa02010; hsa04911; hsa04930 NA 23.1%
11 DHFR P00374 Dihydrofolate reductase hsa00670; hsa00790; hsa01100; hsa01523 22.6%
12 ABL1 P00519 Tyrosine-protein kinase ABL1 hsa04012; hsa04014; hsa04110; hsa04360; hsa04722; hsa05130; hsa05131; hsa05200; hsa05206; hsa05220; hsa05416 22.6%
13 LTB4R Q15722 Leukotriene B4 receptor 1 hsa04080 NA 22.5%
14 MIF P14174 Macrophage migration inhibitory factor hsa00350; hsa00360 22.2%
15 NR3C1 P04150 Glucocorticoid receptor hsa04080 1M2Z; 1NHZ; 1P93; 3BQD; 3CLD; 3E7C; 3H52; 3K22; 3K23; 4CSJ; 4HN5; 4HN6; 4LSJ; 4MDD; 4P6W; 4P6X 21.8%
16 PTGS1 P23219 Prostaglandin G/H synthase 1 hsa00590; hsa01100; hsa04611; hsa04726; hsa04923 NA 21.5%
17 AR P10275 Androgen receptor hsa04114; hsa05200; hsa05215 21.1%
18 ADORA2B P29275 Adenosine receptor A2b hsa04015; hsa04020; hsa04080; hsa04270; hsa05034 NA 21.0%
19 CASP1 P29466 Caspase-1 hsa04217; hsa04621; hsa04623; hsa04625; hsa05014; hsa05132; hsa05133; hsa05134; hsa05164 20.8%
20 TH P07101 Tyrosine 3-monooxygenase hsa00350; hsa00790; hsa01100; hsa04728; hsa04917; hsa05012; hsa05030; hsa05031; hsa05034 2XSN; 4J6S 20.0%


Reference:  Hongchun Li, Fen Pei, D. Lansing Taylor and Ivet Bahar. (2020) QuartataWeb: Integrated Chemical–Protein-Pathway Mapping for Polypharmacology and Chemogenomics. Bioinformatics 36(12), 3935–3937.


The QuartataWeb server is maintained by the Bahar Lab at the Department of Computational & Systems Biology at the University of Pittsburgh, School of Medicine, and sponsored by the NIH awards P41 GM103712 and P01 DK096990; and by the Li Lab at Research Center for Computer-Aided Drug Discovery at Shenzhen Institutes of Advanced Technology, CAS.

For questions and comments please contact Hongchun Li.